Results 111 to 120 of about 4,502 (202)

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant

, 2011
Antiemetics are given to cancer patients prior to their chemotherapy sessions to protect them from nausea and vomiting induced by chemotherapy. The responsible health care team member will choose the type of antiemetic required to prevent the patient ...
Muath Mohammed Abu Hilal
core  

RETRACTION: "Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres". [PDF]

Biomed Res Int
Research International B.
europepmc   +1 more source

Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications. [PDF]

Medicine (Baltimore)
Chen F, Cai D, Wen H, Zhang L.
europepmc   +1 more source

Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]

J Natl Cancer Inst
Botteri E, Hjorth S, Conforti F, Bagnardi V, Andreassen BK, Støer NC, Bhargava S, Ursin G, Gandini S, Sloan EK, Chang A.   +10 more
europepmc   +1 more source

Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. [PDF]

J Minim Invasive Surg
Bala S, Meshram TM, Bhatia P, Rathod D, Kaur M, Kumari K.   +5 more
europepmc   +1 more source

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]

J Endocr Soc
Boretti E, Dogné JM, Douxfils J.
europepmc   +1 more source

Erratum in: Targeting Circadian Rhythm Disruption in Glaucoma: PTGDS Mediates Trabecular Meshwork Fibrosis and Is Therapeutically Targeted by Aprepitant. [PDF]

Transl Vis Sci Technol
europepmc   +1 more source

Aprepitant alleviates acute lung injury in a rat model of hepatic ischemia-reperfusion via NLRP3/IL-1β signaling pathway. [PDF]

Sci Rep
Abdelzaher WY, Kelleni MT, Adly MN, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

Diagnostic and Therapeutic Potential of Substance P/NK1 Receptor in Primary Dysmenorrhea: A Pilot Study. [PDF]

Health Sci Rep
Mehboob R, Shahid I, Alzahrani AR, Yousof SM, Adnan H, Ekram SN, Alwazzan A, Nasief H, Khadawardi KA.   +8 more
europepmc   +1 more source

Three are better than two: redefining prophylaxis for postoperative nausea and vomiting. [PDF]

J Minim Invasive Surg
Kang H.
europepmc   +1 more source